Kai Dallmeier News Today

Christian Brander, Ph.D., is a leading expert on T cell responses to viral infections and brings an important blend of academic and biotech experience.Mala Maini, MD, Ph.D., is a professor of viral immunology at University College London with key expertise in adaptive immunity to hepatitis B, liver cancer, and SARS-CoV-2. Together with the other distinguished vaccine development experts on the company’s scientific advisory board, they will support AstriVax in advancing its innovative plug...

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company. Last month,

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round - led by

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

The Belgian university spinoff AstriVax has generated the biggest seed capital financing in the institution’s history.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Closing on € 30 million, AstriVax has raised the largest amount of...

Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of KU Leuven spin-offs. The company will draw on technology developed at the KU Leuven Rega Institute to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.

ACKERMANS & VAN HAAREN INVESTS IN ASTRIVAX PRESS RELEASE ANTWERP AUGUST... | August 25, 2022